Total Payments
$136,354
2024 Payments
$53,623
Companies
47
Transactions
1,041
Medicare Patients
3,153
Medicare Billing
$325,649
Payment Breakdown by Category
Other$102,908 (75.5%)
Food & Beverage$19,588 (14.4%)
Travel$10,152 (7.4%)
Consulting$3,600 (2.6%)
Education$106.29 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,908 | 43 | 75.5% |
| Food and Beverage | $19,588 | 944 | 14.4% |
| Travel and Lodging | $10,152 | 51 | 7.4% |
| Consulting Fee | $3,600 | 1 | 2.6% |
| Education | $106.29 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $96,513 | 414 | $0 (2024) |
| PFIZER INC. | $21,126 | 58 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $7,502 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,625 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $1,351 | 83 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,288 | 85 | $0 (2024) |
| Boston Scientific Corporation | $1,187 | 6 | $0 (2023) |
| Covidien LP | $571.13 | 4 | $0 (2019) |
| Gilead Sciences, Inc. | $457.46 | 27 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $402.48 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,623 | 206 | ABBVIE INC. ($24,076) |
| 2023 | $12,626 | 162 | ABBVIE INC. ($11,050) |
| 2022 | $19,657 | 154 | ABBVIE INC. ($18,416) |
| 2021 | $11,135 | 85 | AbbVie Inc. ($10,288) |
| 2020 | $8,346 | 98 | AbbVie Inc. ($7,482) |
| 2019 | $10,212 | 133 | AbbVie, Inc. ($7,205) |
| 2018 | $10,475 | 112 | AbbVie, Inc. ($9,097) |
| 2017 | $10,280 | 91 | AbbVie, Inc. ($8,901) |
All Payment Transactions
1,041 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $30.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/27/2024 | PFIZER INC. | VELSIPITY (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/25/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $102.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 626 | 737 | $193,573 | $71,243 |
| 2022 | 13 | 776 | 873 | $218,715 | $76,537 |
| 2021 | 15 | 881 | 1,014 | $231,764 | $91,100 |
| 2020 | 14 | 870 | 1,012 | $225,927 | $86,768 |
Total Patients
3,153
Total Services
3,636
Medicare Billing
$325,649
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 107 | 108 | $51,732 | $19,459 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 160 | $28,958 | $13,806 | 47.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 151 | 166 | $44,156 | $11,901 | 27.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 38 | 38 | $12,730 | $6,352 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $9,663 | $4,530 | 46.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 44 | 45 | $18,135 | $4,294 | 23.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 60 | $6,516 | $3,532 | 54.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 17 | $5,695 | $1,915 | 33.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $3,379 | $1,738 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 26 | $3,343 | $1,459 | 43.7% |
| 43450 | Dilation of esophagus | Facility | 2023 | 42 | 43 | $5,891 | $1,145 | 19.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $3,375 | $1,110 | 32.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 107 | 112 | $53,648 | $19,689 | 36.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 196 | 210 | $55,860 | $14,433 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 169 | $29,279 | $13,662 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 110 | $12,958 | $6,373 | 49.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 31 | 31 | $10,385 | $5,126 | 49.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 55 | 56 | $22,568 | $4,910 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $6,857 | $2,935 | 42.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $6,365 | $2,520 | 39.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 37 | $3,774 | $1,969 | 52.2% |
| 43450 | Dilation of esophagus | Facility | 2022 | 60 | 65 | $8,905 | $1,764 | 19.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,309 | $1,207 | 52.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $2,925 | $1,135 | 38.8% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 11 | 11 | $2,882 | $815.52 | 28.3% |
About Dr. William Lyles, MD
Dr. William Lyles, MD is a Gastroenterology healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750364782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Lyles, MD has received a total of $136,354 in payments from pharmaceutical and medical device companies, with $53,623 received in 2024. These payments were reported across 1,041 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($102,908).
As a Medicare-enrolled provider, Lyles has provided services to 3,153 Medicare beneficiaries, totaling 3,636 services with total Medicare billing of $325,649. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Maryville, TN
- Active Since 11/23/2005
- Last Updated 10/28/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1750364782
Products in Payments
- RINVOQ (Biological) $32,866
- VELSIPITY (Drug) $20,585
- SKYRIZI (Biological) $19,947
- HUMIRA (Biological) $17,275
- Humira (Biological) $10,580
- VOQUEZNA (Drug) $7,502
- STELARA (Biological) $1,239
- GENERAL POLYPECTOMY (Device) $1,147
- XIFAXAN (Drug) $876.26
- ENTYVIO (Biological) $800.33
- LINZESS (Drug) $570.47
- MAVYRET (Drug) $469.84
- XELJANZ (Drug) $467.00
- OCALIVA (Drug) $385.98
- Trulance (Drug) $362.94
- ZEPOSIA (Drug) $317.80
- REMICADE (Biological) $314.74
- TRULANCE (Drug) $297.68
- MOTEGRITY (Drug) $281.21
- INJECTAFER (Drug) $235.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Maryville
Dr. Sirisha Jasti, Md, MD
Gastroenterology — Payments: $8,224
Gastroenterology $8,224
Dr. Frank Wright, M.d, M.D
Gastroenterology — Payments: $8,206
Gastroenterology $8,206
Edmundo Rodriguez-Frias, Md, MD
Gastroenterology — Payments: $7,976
Gastroenterology $7,976
Dr. Jennifer Phemister, M.d, M.D
Gastroenterology — Payments: $5,666
Gastroenterology $5,666
Dr. Isaac Cline, M.d, M.D
Gastroenterology — Payments: $4,763
Gastroenterology $4,763
Dr. Michael Coffey, Md, MD
Gastroenterology — Payments: $3,663
Gastroenterology $3,663